Prenatal And Newborn Genetic Testing Market Opportunities 2024-2033: Size, Growth Analysis, Outlook, and Overview

Overview and Scope Prenatal and newborn genetic testing refers to the medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are performed to detect and identify genetic disorders, congenital conditions, or hereditary diseases that may affect the child's health or development. Sizing and Forecast The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $5.87 billion in 2023 to $6.68 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to improved non-invasive prenatal testing, increased maternal age, government support and healthcare policies, patient demand for early detection.. The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $10.7 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to expanded genetic test panels, increasing maternal health awareness, prenatal and newborn screening guidelines, rising focus on rare diseases, ethical and regulatory considerations.. Major trends in the forecast period include non-invasive prenatal testing (nipt), genome sequencing (wgs) and whole exome sequencing, integration of artificial intelligence (ai), preimplantation genetic testing (pgt), direct-to-consumer genetic testing.. Order your report now for swift delivery, visit the link: https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report Segmentation & Regional Insights The prenatal and newborn genetic testing market covered in this report is segmented – 1) By Product Type: Consumables, Instruments 2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings 3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia 4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers North America was the largest region in the prenatal and newborn genetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa Intrigued to explore the contents? Secure your hands-on a free sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp Major Driver Impacting Market Growth Government initiatives and support for prenatal testing and newborn genetic screening are expected to propel the growth of the prenatal and newborn genetic testing markets going forward. Government initiatives refer to specific actions, programs, policies, or projects undertaken by a government at the local, regional, or national level to address a particular issue, achieve specific goals, or promote the well-being of its citizens. Government initiatives for prenatal and newborn genetic testing support the country's people by helping identify genetic conditions or abnormalities in fetuses during pregnancy or in newborns shortly after birth. For instance, in June 2022, the Australian government allocated $1.3 million annually to the New South Wales (NSW) ( a state on the east coast of Australia) newborn screening program to offer free tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), including newborn genetic testing and screening, to all new babies in the state. The screening tests would be provided to around 100,000 babies each year, saving the lives of up to 13 newborns likely to have these genetic disorders. Therefore, government initiatives and support for prenatal testing and newborn genetic screening drive the prenatal and newborn genetic testing markets. Key Industry Players Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech plc, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc. The prenatal and newborn genetic testing market report table of contents includes: 1. Executive Summary 2. Prenatal And Newborn Genetic Testing Market Characteristics 3. Prenatal And Newborn Genetic Testing Market